Selank (10mg)
$46.99
Selank is a synthetic heptapeptide derived from the immunomodulatory peptide Tuftsin (Thr-Lys-Pro-Arg), with an appended Gly-Glu-Thr sequence to improve metabolic stability. In research settings, Selank is examined for its interactions with GABA-A receptor systems, serotonin pathway modulation, and enkephalin degradation inhibition in central nervous system models.
BioRhex supplies Selank as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.
- In stock
- COA-verified
- ≥99% purity.
- USA manufactured.
- In stock
- COA-verified
- ≥99% purity.
- USA manufactured.
- COA-verified
- In stock
- ≥99% purity.
- USA manufactured.
What Is Selank?
Selank is a synthetic heptapeptide derived from the immunomodulatory peptide Tuftsin (Thr-Lys-Pro-Arg), with an appended Gly-Glu-Thr sequence to improve metabolic stability. In research settings, Selank is examined for its interactions with GABA-A receptor systems, serotonin pathway modulation, and enkephalin degradation inhibition in central nervous system models.
BioRhex supplies Selank as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.
Compound Overview
Selank is a Tuftsin-derived analogue studied for its neurochemical signaling interactions. In vitro and preclinical research models examine how Selank may influence:
• GABA-A receptor modulation and GABAergic pathway signaling dynamics
• Serotonin transporter activity and 5-HT pathway interactions in neuronal models
• Enkephalin-degrading enzyme inhibition and opioid peptide signaling
• BDNF expression modulation in CNS tissue models
• Stress-related neurochemical pathway signaling in preclinical research systems
All findings referenced are from controlled research environments and do not represent clinical outcomes or therapeutic claims.
History of Selank
Selank was developed at the Institute of Molecular Genetics in Moscow as part of research into peptide anxiolytics derived from naturally occurring immunomodulatory peptides. Tuftsin’s tetrapeptide structure was modified to produce a more stable, CNS-active compound.
Research demonstrated Selank’s interactions with GABAergic and serotonergic signaling systems, establishing it as a research tool in anxiolytic pathway pharmacology and neurochemical signaling studies.
Selank remains an active compound in neurocognitive and neurochemical signaling research within controlled laboratory environments.
Molecular Structure
Thr-Lys-Pro-Arg-Pro-Gly-Pro
Research Findings
Published and preclinical research on Selank covers several areas of scientific investigation, including:
GABAergic signaling research: Studies examine Selank’s interaction with GABA-A receptor subtypes and associated inhibitory signaling dynamics.
Serotonergic pathway modeling: Research investigates Selank’s effects on 5-HT transporter activity and serotonin metabolism in neuronal models.
Enkephalin system research: Laboratory studies explore Selank’s inhibitory effects on enkephalin-degrading enzymes and associated opioid signaling dynamics.
Neurotrophin modulation: Preclinical models examine Selank’s effects on BDNF expression and neurotrophic signaling in CNS tissue.
All findings referenced are from controlled, non-clinical research models and do not imply therapeutic or clinical application.
References
FAQ
Q: What type of research is Selank used for?
Q: What type of research is Selank used for?
A: Selank is used in laboratory research settings. All supplied compounds are intended strictly for in vitro and preclinical research purposes. Use is limited to controlled scientific environments.
Q: Where is BioRhex’s Selank manufactured?
Q: Where is BioRhex’s Selank manufactured?
A: All BioRhex compounds, including Selank, are manufactured in a GMP-compliant facility located in the United States.
Q: What testing does BioRhex conduct on Selank?
Q: What testing does BioRhex conduct on Selank?
A: Every batch of Selank undergoes third-party HPLC purity testing, mass spectrometry identity verification, and sterility testing. A Certificate of Analysis is included with every order, documenting batch-specific purity data at a ≥99% threshold.
Q: Is Selank approved for human use?
Q: Is Selank approved for human use?
A: No. Selank is not FDA-approved and is not intended for human or animal administration. It is supplied exclusively for laboratory research purposes.
Q: Who should handle this compound?
Q: Who should handle this compound?
A: Only qualified personnel in controlled laboratory settings following appropriate safety and handling protocols.
Research Use Only
All BioRhex compounds are supplied strictly for laboratory research purposes. Not for human or animal consumption, medical use, or therapeutic application. Selank is not FDA-approved for any medical purpose. Nothing on this page should be interpreted as health guidance or applied outside controlled research settings.
RELATED PRODUCTS
AOD9604 (5mg)
BPC-157
BPC-157 + TB-500
CJC (no DAC) + Ipamorelin (10mg)
